RAFFA, GIUSEPPINA
 Distribuzione geografica
Continente #
NA - Nord America 966
EU - Europa 746
AS - Asia 133
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 2
Totale 1.851
Nazione #
US - Stati Uniti d'America 962
IE - Irlanda 234
SE - Svezia 199
CN - Cina 111
IT - Italia 94
UA - Ucraina 56
DE - Germania 39
PL - Polonia 39
FI - Finlandia 25
FR - Francia 20
GB - Regno Unito 17
IN - India 17
BE - Belgio 15
RU - Federazione Russa 5
CA - Canada 4
VN - Vietnam 4
CL - Cile 2
EU - Europa 2
NZ - Nuova Zelanda 2
ES - Italia 1
HR - Croazia 1
IR - Iran 1
LV - Lettonia 1
Totale 1.851
Città #
Dublin 234
Ashburn 233
Chandler 157
Nyköping 132
Jacksonville 108
Beijing 62
Messina 60
Ann Arbor 53
Warsaw 38
Medford 27
Princeton 27
Houston 26
Cambridge 25
Dearborn 23
Des Moines 22
Pune 17
Boardman 15
Brussels 15
Jinan 12
Woodbridge 10
Wilmington 8
New York 6
Catania 5
San Mateo 5
Tianjin 5
Dong Ket 4
Falls Church 4
Shenyang 4
Zhengzhou 4
Nanjing 3
Ottawa 3
Rome 3
Bremen 2
Changsha 2
Fuzhou 2
Guangzhou 2
Los Angeles 2
Ningbo 2
Norwalk 2
Piazza Armerina 2
Qingdao 2
Rosolini 2
Seattle 2
Villejuif 2
Vittoria 2
Wellington 2
Ardabil 1
Auburn Hills 1
Berlin 1
Boston 1
Caserta 1
Chengdu 1
Chicago 1
Clearwater 1
Edinburgh 1
Haikou 1
Hangzhou 1
Hebei 1
Helsinki 1
Kharkov 1
Kraków 1
Lanzhou 1
Madrid 1
Manchester 1
Modesto 1
Montréal 1
Mountain View 1
Phoenix 1
Redwood City 1
Richland 1
Saint Petersburg 1
Taizhou 1
Tappahannock 1
Trecastagni 1
Zagreb 1
Totale 1.407
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 268
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 127
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 125
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 85
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 83
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 78
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 72
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 60
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 59
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 58
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 58
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 58
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 58
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 57
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 56
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo 54
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 52
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 51
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 51
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 50
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 48
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 48
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 46
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 PRODUCTION WHICH IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY IN HEPATOMA CELL LINES 44
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 42
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 39
null 31
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 26
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 6
Mitochondrial DNA is a target of HBV integration 4
Totale 1.894
Categoria #
all - tutte 5.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.753


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 3 1 5
2019/2020258 33 14 1 12 2 26 26 28 19 41 41 15
2020/2021268 21 4 51 14 28 27 12 33 13 41 11 13
2021/2022196 4 11 16 7 25 5 18 6 3 18 25 58
2022/2023670 40 99 28 40 38 69 22 30 273 4 22 5
2023/2024333 6 31 6 12 9 43 0 219 1 6 0 0
Totale 1.894